Market revenue in 2023 | USD 144.1 million |
Market revenue in 2030 | USD 368.5 million |
Growth rate | 14.4% (CAGR from 2023 to 2030) |
Largest segment | Tavr (transcatheter aortic valve replacement) |
Fastest growing segment | LAAC (Left Atrial Appendage Closure) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | SAVR (Surgical Aortic Valve Replacement), TAVR (Transcatheter Aortic Valve Replacement), Mitral Repair (Annuloplasty), LAAC (Left Atrial Appendage Closure) |
Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Edwards Lifesciences Corp, Abbott Laboratories, St. Jude Medical, LivaNova PLC, Stryker Corp, Lepu Medical, Biomerics, CardioKinetix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to structural heart devices market will help companies and investors design strategic landscapes.
Tavr (transcatheter aortic valve replacement) was the largest segment with a revenue share of 51.63% in 2023. Horizon Databook has segmented the Brazil structural heart devices market based on savr (surgical aortic valve replacement), tavr (transcatheter aortic valve replacement), mitral repair (annuloplasty), laac (left atrial appendage closure) covering the revenue growth of each sub-segment from 2018 to 2030.
The structured heart devices market in Brazil is on a trajectory of robust growth, driven primarily by the country’s escalating burden of CVDs and aortic valve disorders. Lifestyle changes, rapid urbanization, and an aging population are among the key factors contributing to this surge in prevalence.
Recent reports by Braile Biomedical highlight the gravity of the situation, indicating that approximately 150 thousand Brazilians aged over 75 suffer from severe aortic stenosis. According to cardiologist Marcelo Queiroga, this translates to 1 in 20 elderly individuals grappling with the disease, underscoring the urgent need for advanced cardiac interventions.
In addition, the Brazilian government's proactive measures aimed at enhancing healthcare accessibility & fostering the adoption of cutting-edge medical technologies play a pivotal role in propelling market expansion.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil structural heart devices market , including forecasts for subscribers. This country databook contains high-level insights into Brazil structural heart devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account